Evaluation of flow cytometry for the detection of circulating Ewing sarcoma cells

Posted on:
Steven DuBois, MD,  University of California San Francisco
Recipient of the: $25,000 Denis Fedorov Memorial Research Award

Approximately 25% of patients with Ewing sarcoma have circulating EWS fusion transcripts using RT-PCR. RT-PCR has several practical disadvantages. This study will evaluate a flow cytometry method we developed to detect circulating Ewing sarcoma cells. The primary aims are:

1.  To establish the feasibility of this method and
2.  To compare this method to RT-PCR results.

Twenty patients with Ewing sarcoma will enroll. Blood and bone marrow will be evaluated for circulating tumor cells using flow cytometry and RT-PCR. The flow cytometry and RT-PCR results will be compared to determine whether this method merits further evaluation in larger studies.